Breast Cancer Clinical Program Archives - Page 23 of 27

Chuck Perou, PhD (left) presents at the 6th Annual Princess Noorah Oncology Center International Breast Cancer Conference

Three UNC Lineberger members - Lisa Carey, MD, medical director of the UNC Breast Center, division chief of hematology and oncology at the UNC School of Medicine, and physician-in-chief of the N.C. Cancer Hospital, Matt Ewend, MD, Van L. Weatherspoon Jr. Distinguished Professor of Neurosurgery and chair of the UNC Department of Neurosurgery, and Chuck Perou, PhD, professor of genetics and pathology – served as speakers at the 6th Annual Princess Noorah Oncology Center International Breast Cancer Conference held in Jeddah.

The UNC Breast Cancer and the Environment Research Program (BCERP) has announced the official launch of myBCrisk.org, an interactive website designed to increase knowledge about breast cancer risk factors, especially among young African-American women.

Susan G. Komen® has awarded over $875,000 in research funding to UNC Lineberger Comprehensive Cancer Center.

The Metastatic Breast Cancer Network (MBCN) held its 8th Annual National Conference in Chapel Hill September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center.

Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that UNC researcher Zefeng Wang, PhD, discovered is drastically reduced in human lung and breast cancer cells.

UNC Lineberger Comprehensive Cancer Center researchers have developed a new integrated approach to pinpoint the genetic “drivers” of cancer, uncovering eight genes that could be viable for targeted breast cancer therapy. The study, published online August 24 in Nature Genetics, was authored by Michael Gatza, PhD, lead author and post-doctoral research associate; Grace Silva, graduate student; Joel Parker, PhD, director of bioinformatics, UNC Lineberger; Cheng Fan, research associate; and senior author Chuck Perou, PhD, professor of genetics and pathology.

Obesity, epidemic in the U.S. and worldwide, is one of the important modifiable risk factors for breast cancer, especially a particularly aggressive subtype called basal-like breast cancer (BBC). Population studies have suggested that lifestyle interventions, including weight loss, could prevent a large proportion of this type of cancer; however, data on the effect of weight loss on BBC risk are limited and the mechanisms involved uncertain.

Physical activity after breast cancer diagnosis has been linked with prolonged survival and improved quality of life, but most participants in a large breast cancer study did not meet national physical activity guidelines after they were diagnosed.

New research by Stephanie B. Wheeler, PhD; Katie Reeder-Hayes, MD; and Anne Marie Meyer, PhD, reveals that breast cancer patients insured by Medicaid and African-American breast cancer patients are less likely to receive life-saving endocrine therapy (ET) to prevent cancer recurrence.

The UCRF, a $42 million, state-appropriated fund established in 2007, continues to have a significant impact on cancer research in North Carolina.

Tag: Breast Cancer Clinical Program

UNC Lineberger researchers present at international breast cancer conference in Saudi Arabia

New website launched to help women learn about risk factors for breast cancer

Komen awards more than $875,000 to UNC Lineberger researchers

UNC Lineberger hosts Metastatic Breast Cancer Network Conference

UNC researchers find new genetic target for a different kind of cancer drug

UNC Lineberger researchers develop new approach to identify “drivers” of cancer

Study in mice finds weight loss reduces progression of basal-like breast cancer

Most Breast Cancer Patients May Not Be Getting Enough Exercise

Wheeler and Reeder-Hayes research shows African-American women and those insured by Medicaid less likely to receive endocrine therapy to prevent breast cancer recurrence

2013-2014 University Cancer Research Fund Annual Report now available